MATINAS BIOPHARMA HOLDINGS, INC. Financing Cash Flow
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Financing Cash Flow of -$1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $58.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $64.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $1.62M, a 82.35% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $1.65M, a 3007.55% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $3.39M, a 63.04% decline from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $9.17M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$7.00K, a 108.86% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $79.00K, a 98.87% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-13 | |||||||
| 2025-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $122.00K derived: sum of 2 quarters · filed 2026-03-31 | $1.74M derived: sum of 3 quarters · filed 2026-08-13 | $3.39M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.69M derived: sum of 2 quarters · filed 2026-08-13 | $3.33M 10-Q · filed 2025-11-10 | $3.33M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.27M 10-Q · filed 2026-08-13 | $3.27M derived: sum of 3 quarters · filed 2026-08-13 | $3.20M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.65M 10-Q · filed 2026-05-08 | $1.65M derived: sum of 2 quarters · filed 2026-05-08 | $1.58M derived: sum of 3 quarters · filed 2026-05-08 | $10.77M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$68.00K derived: sum of 2 quarters · filed 2026-03-31 | $9.12M derived: sum of 3 quarters · filed 2026-03-31 | $9.17M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $9.12M derived: sum of 2 quarters · filed 2025-11-10 | $9.18M 10-Q · filed 2025-11-10 | $9.17M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $9.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $9.24M 10-Q · filed 2025-08-14 | $9.24M derived: sum of 3 quarters · filed 2025-08-14 | $9.24M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $53.00K 10-Q · filed 2025-05-15 | $52.00K derived: sum of 2 quarters · filed 2025-05-15 | $51.00K derived: sum of 3 quarters · filed 2025-05-15 | $50.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$2.00K derived: sum of 2 quarters · filed 2025-04-15 | -$3.00K derived: sum of 3 quarters · filed 2025-04-15 | -$7.00K 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$2.00K derived: sum of 2 quarters · filed 2024-11-13 | -$6.00K 10-Q · filed 2024-11-13 | -$11.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$5.00K 10-Q · filed 2024-08-14 | -$10.00K derived: sum of 3 quarters · filed 2024-08-14 | -$13.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$4.00K 10-Q · filed 2024-05-09 | -$9.00K derived: sum of 2 quarters · filed 2024-05-09 | -$12.00K derived: sum of 3 quarters · filed 2024-05-09 | -$18.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$8.00K derived: sum of 2 quarters · filed 2024-03-27 | -$14.00K derived: sum of 3 quarters · filed 2024-03-27 | $79.00K 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$9.00K derived: sum of 2 quarters · filed 2023-11-08 | $84.00K 10-Q · filed 2023-11-08 | $83.64K 10-Q · filed 2022-11-02 | $92.33K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $87.00K 10-Q · filed 2023-08-09 | $87.29K 10-Q · filed 2022-08-11 | $95.33K derived: sum of 3 quarters · filed 2023-08-09 | $87.01K derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $93.00K 10-Q · filed 2023-05-10 | $92.92K 10-Q · filed 2022-05-12 | $101.33K derived: sum of 2 quarters · filed 2023-05-10 | $93.01K derived: sum of 3 quarters · filed 2023-05-10 | $273.48K derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $8.33K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $6.00 derived: sum of 2 quarters · filed 2023-03-15 | $180.48K derived: sum of 3 quarters · filed 2023-03-15 | $6.96M 10-K · filed 2023-03-15 | $6.96M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | -$8.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $172.15K derived: sum of 2 quarters · filed 2022-11-02 | $6.96M 10-Q · filed 2022-11-02 | $7.51M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $180.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $6.96M 10-Q · filed 2022-08-11 | $7.51M derived: sum of 3 quarters · filed 2022-08-11 | $7.57M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $6.78M 10-Q · filed 2022-05-12 | $7.33M derived: sum of 2 quarters · filed 2022-05-12 | $7.39M derived: sum of 3 quarters · filed 2022-05-12 | $7.39M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $549.57K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $603.77K derived: sum of 2 quarters · filed 2022-03-11 | $607.49K derived: sum of 3 quarters · filed 2022-03-11 | $48.05M 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | $54.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $57.92K derived: sum of 2 quarters · filed 2021-11-08 | $47.50M 10-Q · filed 2021-11-08 | $47.51M derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | $3.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $47.44M 10-Q · filed 2021-08-10 | $47.45M derived: sum of 3 quarters · filed 2021-08-10 | $47.43M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $47.44M 10-Q · filed 2021-05-10 | $47.45M derived: sum of 2 quarters · filed 2021-05-10 | $47.43M derived: sum of 3 quarters · filed 2021-05-10 | $47.26M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $10.29K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$9.24K derived: sum of 2 quarters · filed 2021-03-29 | -$176.24K derived: sum of 3 quarters · filed 2021-03-29 | $29.85M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$19.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$186.53K derived: sum of 2 quarters · filed 2020-11-06 | $29.84M 10-Q · filed 2020-11-06 | $38.20M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $29.86M 10-Q · filed 2020-08-10 | $38.22M derived: sum of 3 quarters · filed 2020-08-10 | $38.86M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $30.03M 10-Q · filed 2020-05-11 | $38.39M derived: sum of 2 quarters · filed 2020-05-11 | $39.03M derived: sum of 3 quarters · filed 2020-05-11 | $46.03M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $8.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $9.00M derived: sum of 2 quarters · filed 2020-03-09 | $16.00M derived: sum of 3 quarters · filed 2020-03-09 | $15.87M 10-K · filed 2020-03-09 | ||||
| 2018-09-30 | $642.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $7.64M derived: sum of 2 quarters · filed 2019-11-13 | $7.51M 10-Q · filed 2019-11-13 | $7.85M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $6.87M 10-Q · filed 2019-08-13 | $7.21M derived: sum of 3 quarters · filed 2019-08-13 | $7.76M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$135.69K 10-Q · filed 2019-05-13 | $203.68K derived: sum of 2 quarters · filed 2019-05-13 | $756.86K derived: sum of 3 quarters · filed 2019-05-13 | $705.88K derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $339.37K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $892.55K derived: sum of 2 quarters · filed 2019-04-01 | $841.57K derived: sum of 3 quarters · filed 2019-04-01 | $15.60M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | $553.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $502.20K derived: sum of 2 quarters · filed 2018-11-09 | $15.26M 10-Q · filed 2018-11-09 | $15.27M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$50.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $14.71M 10-Q · filed 2018-08-09 | $14.71M derived: sum of 3 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $14.76M 10-Q · filed 2018-05-09 | $14.76M derived: sum of 2 quarters · filed 2018-05-09 | ||||||
| 2016-12-31 | $1.81K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $7.00M 10-K · filed 2018-03-16 | ||||||
| 2016-09-30 | $7.00M 10-Q · filed 2017-11-14 | |||||||
| 2015-12-31 | $8.46M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |